Evaluating the Efficacy and Safety of of HSK44459 in People With Progressive Pulmonary Fibrosis

Summary

This study is open to adults with PPF . The main objective is to evaluate of the efficacy and the secondary objective is to evaluate the safety and pharmacokinetic.

Timeline

Start

2026-04-05

Primary completion

2028-12-30

Completion

2029-03-01

Drugs

Indications